Reviva Pharmaceuticals Holdings Inc (RVPH) Balance Sheet

Total equity

Cash, cash equivalents and short-term investments

-55.82%5.29M

-42.33%13.48M

11.80%5.56M

-44.60%6.18M

6.38%11.97M

26.18%23.37M

-78.56%4.97M

-42.58%11.15M

-51.94%11.26M

-37.62%18.52M

-30.75%23.19M

-45.76%19.42M

314.96%23.42M

42754.59%29.69M

24836.43%33.49M

16848.23%35.80M

1962.30%5.64M

-77.87%69.28K

-66.50%134.31K

-52.16%211.24K

--273.69K

--313.05K

--400.96K

--441.57K

- Cash and cash equivalents

-55.82%5.29M

-42.33%13.48M

11.80%5.56M

-44.60%6.18M

6.38%11.97M

26.18%23.37M

-78.56%4.97M

-42.58%11.15M

-51.94%11.26M

-37.62%18.52M

-30.75%23.19M

-45.76%19.42M

314.96%23.42M

42754.59%29.69M

24836.43%33.49M

16848.23%35.80M

1962.30%5.64M

-77.87%69.28K

-66.50%134.31K

-52.16%211.24K

--273.69K

--313.05K

--400.96K

--441.57K

Prepaid expenses

-36.45%967.92K

262.55%1.21M

201.71%1.25M

52.77%1.05M

-7.47%1.52M

-17.55%332.93K

-51.15%414.74K

-43.56%690.44K

-10.89%1.65M

-76.47%403.82K

111.03%849.02K

66.69%1.22M

82.51%1.85M

2366.17%1.72M

2469.72%402.32K

1802.71%733.93K

1481.55%1.01M

-23.64%69.58K

-74.14%15.66K

-50.67%38.57K

--63.99K

--91.13K

--60.55K

--78.20K

Other current assets

--0.00

----

--1.82K

----

Total current assets

-53.64%6.26M

-38.05%14.68M

26.42%6.81M

-38.92%7.23M

4.61%13.50M

25.24%23.70M

-77.59%5.39M

-42.64%11.84M

-48.94%12.90M

-39.74%18.92M

-29.07%24.04M

-43.50%20.64M

279.51%25.27M

22515.58%31.40M

22501.38%33.89M

14525.06%36.53M

1871.73%6.66M

-65.64%138.86K

-67.51%149.96K

-51.94%249.81K

--337.68K

--404.18K

--461.51K

--519.77K

Non-current assets

Net Fixed Assets

----

--0.00

----

-Fixed Assets

----

--41.71K

----

-Accumulated depreciation

----

--41.71K

----

Long-term prepaid expenses

--819.72K

----

Other non-current assets

--819.72K

----

--1.82K

----

Total non-current assets

--819.72K

----

-6.68%60.88M

2.23%66.32M

2.30%66.02M

--65.65M

--65.24M

--64.88M

--64.54M

Total assets

-47.56%7.08M

-34.59%15.50M

41.63%7.63M

-32.00%8.05M

4.61%13.50M

25.24%23.70M

-77.59%5.39M

-42.64%11.84M

-48.94%12.90M

-39.74%18.92M

-29.07%24.04M

-43.50%20.64M

279.51%25.27M

-48.54%31.40M

-49.01%33.89M

-44.87%36.53M

-89.91%6.66M

-7.04%61.02M

1.74%66.47M

1.87%66.27M

--65.99M

--65.65M

--65.34M

--65.05M

Liabilities

Current liabilities

-Other payables

--0.00

----

--0.00

----

--0.00

----

--0.00

----

Accrued expenses

-22.22%6.56M

-41.02%7.86M

15.15%8.67M

42.69%9.04M

178.33%8.44M

106.87%13.33M

513.40%7.53M

229.37%6.34M

37.97%3.03M

251.00%6.44M

122.08%1.23M

139.18%1.92M

248.81%2.20M

465.21%1.84M

--552.92K

--804.49K

--630.04K

--324.70K

----

Short-term debt and lease liabilities

-32.44%224.30K

--458.15K

-62.70%83.00K

-6.74%207.50K

-50.26%332.00K

----

--222.50K

--667.50K

----

--0.00

----

--0.00

----

-Short-term debt

-32.44%224.30K

--458.15K

-62.70%83.00K

-6.74%207.50K

-50.26%332.00K

----

--222.50K

--667.50K

----

Other current liabilities

--0.00

----

--0.00

----

--0.00

----

--0.00

----

Total current liabilities

-20.58%11.51M

-14.98%14.60M

34.53%17.53M

51.43%13.94M

120.91%14.49M

72.41%17.18M

264.49%13.03M

105.66%9.21M

81.05%6.56M

324.85%9.96M

267.23%3.58M

285.07%4.48M

229.00%3.62M

682.51%2.34M

872.71%973.70K

3327.29%1.16M

3878.27%1.10M

1200.01%299.65K

346.82%100.10K

2131.97%33.93K

--27.68K

--23.05K

--22.40K

--1.52K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

-100.00%0.00

--0.00

--750.00K

--0.00

-Long-term debt

----

--0.00

----

--0.00

-100.00%0.00

--0.00

--750.00K

--0.00

----

Other non-current liabilities

-92.06%27.82K

-88.97%89.01K

-91.08%77.88K

-85.16%150.21K

-37.00%350.48K

42.16%806.65K

726.32%873.41K

857.90%1.01M

96.08%556.31K

52.24%567.44K

-83.76%105.70K

-87.58%105.70K

-72.73%283.72K

-83.16%372.73K

-70.60%650.89K

-61.55%851.16K

-53.01%1.04M

0.00%2.21M

--2.21M

Total non-current liabilities

-92.06%27.82K

-88.97%89.01K

-91.08%77.88K

-85.16%150.21K

-37.00%350.48K

42.16%806.65K

726.32%873.41K

857.90%1.01M

96.08%556.31K

52.24%567.44K

-83.76%105.70K

-87.58%105.70K

-72.73%283.72K

-87.42%372.73K

-70.60%650.89K

-61.55%851.16K

-53.01%1.04M

33.88%2.96M

0.00%2.21M

--2.21M

Total liabilities

-22.27%11.54M

-18.30%14.69M

26.64%17.61M

37.90%14.09M

108.56%14.84M

70.78%17.98M

277.75%13.91M

123.01%10.22M

82.14%7.12M

287.46%10.53M

126.61%3.68M

127.57%4.58M

82.44%3.91M

-16.73%2.72M

-29.79%1.62M

-10.40%2.01M

-4.45%2.14M

45.90%3.26M

3.47%2.31M

1.46%2.25M

--2.24M

--2.22M

Shareholders' equity

Common equity

18.37%166.25M

17.86%165.09M

31.95%148.03M

28.41%143.61M

35.62%140.44M

35.35%140.07M

8.49%112.19M

16.99%111.84M

8.37%103.56M

8.34%103.49M

8.38%103.41M

0.22%95.60M

49.83%95.56M

68.86%95.52M

51.85%95.42M

51.81%95.39M

1.50%63.78M

-9.98%56.57M

0.00%62.84M

--62.84M

Retained earnings

-20.40%-170.71M

-22.27%-164.27M

-30.91%-158.01M

-35.78%-149.65M

-45.02%-141.79M

-41.29%-134.35M

-45.34%-120.71M

-38.57%-110.22M

-31.78%-97.77M

-42.29%-95.09M

-31.52%-83.05M

-30.67%-79.54M

-25.21%-74.20M

-5706.55%-66.83M

-4870.55%-63.15M

-5228.40%-60.87M

-6593.77%-59.26M

107.62%1.19M

394.71%1.32M

27209.64%1.19M

--912.56K

--574.13K

--267.57K

--4.35K

Capital reserves

18.37%166.24M

17.86%165.08M

31.95%148.03M

28.41%143.60M

35.62%140.44M

35.35%140.07M

8.49%112.19M

16.99%111.84M

8.37%103.56M

8.34%103.49M

8.38%103.41M

0.22%95.60M

49.83%95.56M

45.30%95.52M

--95.42M

--95.39M

--63.77M

--65.74M

----

Total equity

-231.40%-4.46M

-85.79%812.57K

-17.17%-9.98M

-472.66%-6.04M

-123.26%-1.35M

-31.87%5.72M

-141.84%-8.52M

-89.91%1.62M

-72.92%5.78M

-70.74%8.39M

-36.91%20.36M

-53.48%16.06M

372.96%21.36M

-50.33%28.69M

-49.70%32.27M

-46.08%34.52M

-92.92%4.52M

-8.91%57.76M

1.67%64.16M

1.88%64.02M

--63.75M

--63.41M

--63.10M

--62.84M

Currency unit

USD

Audit opinions

--

Reviva Pharmaceuticals Holdings Inc

0.453USD

Reviva Pharmaceuticals Holdings Inc

0.453

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement